Achieving a durable and efficient antiangiogenic response will require approaches to simultaneously or sequentially target multiple aspects of the tumor microenvironment
This phenomenon, as explored by scholars such as Epstein (2005), Leyshon and Thrift (2007), Krippner (2011), Gotham (2012), Christophers (2015), Raco et al
Each production batch is third-party tested, and Certificates of Analysis are provided to document analytical verification, purity assessment, and identity confirmation
If you have any additional questions regarding the availability of testing, please contact our laboratory by telephone or email.** Please note, this test is performed by LabCorp and will not require a physical test kit to complete your draw